Treatment of cardiac tissue via an implantable heart treatment device is described. A device embodiment includes, but is not limited to, a substrate configured for implantation within a body; an electromagnetic signal generator coupled to the substrate and configured to generate one or more electric signals configured to stimulate one or more tissues of a heart; and an oxygenator coupled to the substrate and configured to supply one or more oxygenated molecules to one or more tissues of the heart, the oxygenator including a blood inlet portion, a blood outlet portion, and an oxygen exchange portion positioned between the blood inlet portion and the blood outlet portion, the oxygen exchange portion including a high surface area oxygen exchanger configured to transfer one or more oxygenated molecules from the high surface area oxygen exchanger to blood passing from the blood inlet portion to the blood outlet portion.

A method of improving hemodynamics includes identifying a mammal having or at risk of developing a vascular depletion of nitric oxide due to nitric oxide scavenging by oxyhemoglobin, and introducing nitric oxide into the mammal's circulation.

Treatment of cardiac tissue via an implantable heart treatment device is described. A device embodiment includes, but is not limited to, a substrate; an electromagnetic signal generator configured to generate one or more electric signals configured to stimulate one or more tissues of a heart; a metabolic molecule supply device configured to supply one or more metabolic molecules to one or more tissues of the heart; and control circuitry operably coupled to the electromagnetic signal generator and the metabolic molecule supply device, the control circuitry configured to generate one or more control signals according to at least a first control protocol and a second control protocol, dependent upon a status of a ventricular fibrillation event of the heart.

A gas/fluid mass exchange apparatus includes a gas permeable membrane which is arranged to separate a first region for receiving a gas flow, from a second region for receiving a fluid flow. The apparatus further a support element which is arranged to maintain the shape and orientation of the membrane.

A system for safely delivering an efficient amount of oxygen to essential organs, during cardiopulmonary resuscitation (CPR) is described; a respective method and an endotracheal device for delivering a semi-spontaneous positive-pressure ventilation are further described; the system comprises; at least one limb compression device, a positive-pressure ventilation system, an endotracheal tube, a cardiac stimulation device, an intra-tracheal pressure sensor, a synchronizer; the method comprises; compressing at least one limb device and occluding a blood flow into the limb, delivering a mixture of gases, providing an endotracheal tube, conferring a deployed configuration, conferring a withheld configuration, performing a cardiac stimulation device, determining a pressure, synchronizing a timing; the endotracheal device comprises; an elongated tube, a sealing cuff assuming a deployed configuration and withheld

A system including tubing and a filter configured to be fluidly coupled to a vacuum source and to a heater/cooler unit by the tubing. The filter includes a filter container having negative air pressure in the filter container provided by the vacuum source to pull aerosol from the heater/cooler unit into the filter container and eliminate and/or reduce the aerosol emitted from the heater/cooler unit.

An artificial lung system for a patient having a membrane lung system having an gas inlet, a blood inlet, a blood outlet, and an exhaust; a gas system operably coupled to the gas inlet of the membrane lung system; a gas phase CO.sub.2 sensor disposed downstream of the exhaust of the membrane lung system and monitoring an exhaust gas CO.sub.2 (EGCO.sub.2) level and/or an blood oxygen saturation sensor disposed upstream of the blood inlet of the membrane lung system and monitoring a blood oxygen saturation level; and a feedback controller receiving the CO.sub.2 signal and/or blood oxygen saturation signal and outputting a control signal to control gas flow and/or blood flow.

The present invention presents a novel oxygenator of the invention provides a revolutionary engineering design and management of the flow regime in a completely different way from the existing and accepted regime in the field of oxygenators, that further lower the risk levels associated with the use of oxygenators and reduces the manufacturing cost. The revolutionary technology is aimed to divert the world of blood oxygenation from the use of technology that relies on a fiber membrane or gas bubbles and causes substantial damage to the patient's blood, towards the use of technology that allows the exchange of gases without a membrane at all and is aimed to reduces risks and improves patient outcome.

The invention relates to a holding means for holding an oxygenator and a blood pump. The holding means is characterised by a frame that can be connected with a carrying case housing in a torque-proof way for fitting the oxygenator and the blood pump relative to each other, wherein the frame has a frame section for connection with the oxygenator in a torque-proof way and another frame section for connection with the blood pump in a torque-proof way.

A method of treating thrombosis in a subject comprising administering an effective amount of a PDE4 inhibitor.